ITC Issues Notice of Commission Determination to Affirm the Final Initial Determination and to Terminate the Investigation into the Coenzyme Q10 Manufacturers and Their Distributors in China, Japan and the United States
February 08, 2013
In its Notice and Opinion the ITC affirmed the Final Initial Determination, which found that Kaneka’s US patent No. 7,910,340 (‘340 patent) was valid, but the evidence was insufficient to find infringement of the ‘340 patent by Respondents.
As Kaneka strongly disagreed with the Final Initial Determination, Kaneka will continue to proceed with pending infringement lawsuits in the U.S. District Court for the Southern District of Texas and for the Central District Court of California, in which the same companies named as Respondents in the ITC proceeding are alleged to have infringed Kaneka’s ‘340 patent.